Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

source https://finance.yahoo.com/news/top-performing-biotech-etfs-ytd-214609026.html?.tsrc=rss